These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 36804828)

  • 1. PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions-a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions.
    Mudhar HS; Milman T; Stevenson S; Watson M; Kim J; Magan T; Salvi SM; Harley U; Lally SE; Shields CL
    Hum Pathol; 2023 Apr; 134():1-18. PubMed ID: 36804828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRAME immunohistochemistry is useful in the evaluation of conjunctival melanomas, nevi, and primary acquired melanosis.
    LeBlanc RE; Miller DM; Zegans ME
    J Cutan Pathol; 2021 Dec; 48(12):1442-1448. PubMed ID: 34089198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRAME expression in genital melanocytic lesions - Potential diagnostic pitfall of intermediate expression in atypical genital nevi.
    Ng JKM; Choi PCL; Chow C; Li JJX; To KF
    Pathol Res Pract; 2024 Aug; 260():155404. PubMed ID: 38878667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential diagnostic utility of PRAME and p16 immunohistochemistry in melanocytic nevi and malignant melanoma.
    Bahmad HF; Oh KS; Alexis J
    J Cutan Pathol; 2023 Aug; 50(8):763-772. PubMed ID: 37114299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors.
    Lezcano C; Jungbluth AA; Busam KJ
    Am J Surg Pathol; 2020 Jul; 44(7):893-900. PubMed ID: 32317605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRAME Expression in Melanocytic Tumors.
    Lezcano C; Jungbluth AA; Nehal KS; Hollmann TJ; Busam KJ
    Am J Surg Pathol; 2018 Nov; 42(11):1456-1465. PubMed ID: 30045064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refining the application of PRAME-a useful marker in high CSD and acral melanoma subtypes.
    Wakefield C; O'Keefe L; Heffron CCBB
    Virchows Arch; 2023 Dec; 483(6):847-854. PubMed ID: 37723345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRAME Expression in Junctional Melanocytic Proliferations of the Conjunctiva: A Potential Biomarker for Primary Acquired Melanosis/Conjunctival Melanocytic Intraepithelial Lesions.
    Huang YY; Hrycaj SM; Chan MP; Stagner AM; Patel RM; Bresler SC
    Am J Dermatopathol; 2022 Oct; 44(10):734-740. PubMed ID: 35475786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferentially Expressed Antigen in Melanoma Immunostaining in a Series of Melanocytic Neoplasms.
    Googe PB; Flanigan KL; Miedema JR
    Am J Dermatopathol; 2021 Nov; 43(11):794-800. PubMed ID: 33989214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRAME immunohistochemistry is useful in differentiating oral melanomas from nevi and melanotic macules.
    Schmitt TA; Lee JC; Martinka M; Ko KYC
    J Cutan Pathol; 2023 Mar; 50(3):275-278. PubMed ID: 36398487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRAME Immunohistochemical Expression and TERT Promoter Mutational Analysis as Ancillary Diagnostic Tools for Differentiating Proliferative Nodules From Melanoma Arising in Congenital Nevi.
    Boutko A; Hagstrom M; Lampley N; Roth A; Olivares S; Dhillon S; Fumero-Velázquez M; Benton S; Zhao J; Zhang B; Dittmann D; Asadbeigi S; Busam KJ; Gerami P
    Am J Dermatopathol; 2023 Jul; 45(7):437-447. PubMed ID: 37338065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of combining PRAME and HMB-45 stains in primary melanocytic tumors.
    Rasic D; Korsgaard N; Marcussen N; Precht Jensen EM
    Ann Diagn Pathol; 2023 Dec; 67():152211. PubMed ID: 37717457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.
    Busam KJ; Fang Y; Jhanwar SC; Pulitzer MP; Marr B; Abramson DH
    J Cutan Pathol; 2010 Feb; 37(2):196-203. PubMed ID: 20100177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features.
    Raghavan SS; Wang JY; Kwok S; Rieger KE; Novoa RA; Brown RA
    J Cutan Pathol; 2020 Dec; 47(12):1123-1131. PubMed ID: 32700786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shedding light on PRAME expression in dysplastic nevi: a cohort study.
    Innocenti L; Scarpitta R; Corraro S; Ortenzi V; Bonadio AG; Loggini B; De Ieso K; Naccarato AG; Fanelli GN; Scatena C
    Virchows Arch; 2024 Jul; 485(1):97-104. PubMed ID: 38112793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRAME/MELAN-A double immunostaining as a diagnostic tool for conjunctival melanocytic lesions: A South American experience.
    Carvajal P; Zoroquiain P
    Pathol Res Pract; 2023 Oct; 250():154776. PubMed ID: 37696245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of PRAME staining in identifying malignant transformation of melanocytic nevi.
    Lohman ME; Steen AJ; Grekin RC; North JP
    J Cutan Pathol; 2021 Jul; 48(7):856-862. PubMed ID: 33433032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16ink4a expression in benign and malignant melanocytic conjunctival lesions.
    Zoroquiain P; Fernandes BF; González S; Novais GN; Schalper KA; Burnier MN
    Int J Surg Pathol; 2012 Jun; 20(3):240-5. PubMed ID: 22287653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRAME Immunohistochemistry for Distinguishing Vulvar and Vaginal Melanoma From Benign Melanocytic Nevi.
    Martin SD; Martin KC; Gilks CB; Crawford RI; Hoang LN
    Int J Gynecol Pathol; 2024 Jul; 43(4):389-396. PubMed ID: 38085951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRAME expression in melanocytic lesions of the nail.
    Parra O; Linos K; Li Z; Yan S
    J Cutan Pathol; 2022 Jul; 49(7):610-617. PubMed ID: 35294053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.